Business
Imagion (ASX:IBX) share price up 1,166% in a year pursuing ‘radiation-free’ cancer tech
The Imagion Biosystems Ltd (ASX: IBX) share price has rocketed 1,166% over the past 12 months due to a series of promising projects around cancer detection.
The company’s bio is truly a mouthful: its principal business activities consist of nanotechnology, biotechnology, cancer diagnostics, and – the clincher — superparamagnetic relaxometry.
What investors should know is that it develops medical devices focused around cancer screening technology.
Imagion’s Magsense cancer screening technology
One of these tech projects, called Magsense, is a diagnostic imaging tool that can potentially increase…
-
General23 hours agoWondering about winter | The Spectator Australia
-
General22 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash
-
Noosa News22 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
Noosa News21 hours agoGabby Petito died after experiencing domestic violence. Young Aussies are identifying with her story